This differs from other neurodegenerative diseases, where the definite diagnosis relies on neuropathological findings and not on a CSF/blood-based test, and reflects one of the unique features of anti-IgLON5 disease, the combination of autoimmunity and neurodegeneration. This evidence concerns the gene IGLON5 and neurodegenerative disease.